Dr. Brendan M. Finnerty, MD

Dr. Finnerty practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Finnerty's NPI, 1962727495, was assigned on March 27, 2010. Dr. Finnerty graduated from University of Illinois College of Medicine - Chicago in 2010. Dr. Finnerty's New York license number on file is 274844.

Dr. Finnerty's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Finnerty's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Finnerty to 2 more clinical labs, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finnerty practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Finnerty's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Finnerty is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Finnerty's licenses on file in 2 states: New York and Connecticut.

Dmand AI lists esophagus, stomach, or upper small intestine surgery, groin hernia surgery and thyroid surgery among the conditions Dr. Finnerty treats.

CMS data shows 317 Medicare services from Dr. Finnerty across 10 procedure codes in 2024, for 157 Medicare patients. Medicare paid $50,711 for them.

CMS counts 157 Medicare patients who saw Dr. Finnerty in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Finnerty's median patient age at 61, with 74% women.

In 2024, Dr. Finnerty wrote 14 Medicare Part D claims. 86% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $58 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Finnerty for performance year 2024, reported through an alternative payment model (APM). Dr. Finnerty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Finnerty as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 79 papers to Dr. Finnerty, published from 2014 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Thyroid Neoplasms, Thyroidectomy and Gastroesophageal Reflux. Dr. Finnerty has published most often in Surgery. Dr. Finnerty's most frequent co-authors are Rasa Zarnegar, MD, Toni Beninato, MD and Caitlin Egan.

CMS Open Payments shows 34 general payments to Dr. Finnerty from 12 drug and device companies from 2017 to 2025. Education make up the largest share, 92% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $50,000.

Dr. Finnerty graduated from University of Illinois College of Medicine - Chicago in 2010. Dr. Finnerty is a member of American Association of Endocrine Surgeons, ACS, ATA, Association for Academic Surgery and North American Neuroendocrine Tumor Society (NANETS).

Dr. Finnerty is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.